Risk of prostate cancer is not associated with levels of C‐reactive protein and other commonly used markers of inflammation
Open Access
- 15 November 2010
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 129 (6) , 1485-1492
Abstract
Most population-based studies studied the association between inflammation and prostate cancer (PCa) by assessing C-reactive protein (CRP). As these findings have shown inconsistent results, we aimed to also study different markers that have been commonly taken as indications of inflammation. A cohort based on four groups of men (n = 34,891), according to age at cohort entry (45, 55, 65 and 75 years), with measurements of glucose, triglycerides, total cholesterol, haptoglobin, albumin, hemoglobin and leukocytes were selected from the Apolipoprotein Mortality Risk database. A total of 17,937 men had measurements of non-high-sensitive CRP. Multivariate Cox proportional hazard models were used to analyze associations between inflammatory markers and PCa. A total of 49 of 12,063 men developed PCa in the age 45 group, whereas 207 of 9,940, 472 of 8,266 and 276 of 3,618 were diagnosed in the age 55, 65 and 75 groups, respectively. Mean follow-up time was 7.5 years (SD: 3.9). No markers showed an association with PCa risk, nor was there a trend by quartiles or an indication for different PCa risks by strata of hypercholesterolemia, hyperglycemia and hypertriglyceridemia status. The studied markers were not found to be associated with PCa risk. These null findings might be due to methodological issues; however, it is unlikely that strong and long-lasting associations between inflammation and PCa risk were missed as this was a large database with long follow-up. This indicates need for international consensus on appropriate inflammatory markers in the context of cancer that may be practically applied in large studies.Keywords
This publication has 38 references indexed in Scilit:
- The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome StudyBritish Journal of Cancer, 2010
- Diet, Supplement Use, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention TrialAmerican Journal of Epidemiology, 2010
- Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of CancerCancer Epidemiology, Biomarkers & Prevention, 2009
- Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophagesCancer Letters, 2009
- Circulating prediagnostic interleukin‐6 and C‐reactive protein and prostate cancer incidence and mortalityInternational Journal of Cancer, 2009
- C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and olderCancer Causes & Control, 2009
- Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsivenessNDT Plus, 2009
- Physical Activity, White Blood Cell Count, and Lung Cancer Risk in a Prospective Cohort StudyCancer Epidemiology, Biomarkers & Prevention, 2008
- A systematic review of the association between circulating concentrations of C reactive protein and cancerJournal of Epidemiology and Community Health, 2007
- Inflammation in prostate carcinogenesisNature Reviews Cancer, 2007